News

IRI announces new senior partners in consulting and innovation practice division

BY Allison Cerra

CHICAGO Further expanding its ongoing efforts to bring high-value consulting and strategic advisory services and solutions to its clients worldwide, Information Resources Inc. introduced two senior partners within the IRI consulting and innovation practice.

Krishnakumar (KK) S. Davey, Ph.D. and Ed See will lead growth initiatives within the IRI consulting and innovation practice, focused on developing and applying next generation analytic marketing capabilities to solve a variety of client business problems and provide the critical strategy, insight, and direction to IRI’s wide range of consumer packaged goods retailer and manufacturer clients. Both professionals will take client leadership roles in many of IRI’s key accounts to develop the required framework, supporting capabilities and the right talent for delivering an entirely new level of influence and advice that leverages IRI’s unique assets, including its predictive analytics, deep consumer and shopper insights and enabling technologies.

“Many of our clients are looking to IRI for that next level of Insight—with a capital ‘I’—to help them drive their business forward,” said the division’s president Thom Blischok. “IRI is eager to help support this shift and KK and Ed bring tremendous experience to IRI that will directly translate into an improved ability to help our CPG, healthcare and retail clients better understand and ultimately serve their consumers and shoppers.  The combination of Ed and KK’s significant experience combined with IRI’s collection of capabilities bring to bear a powerful force to drive next generation thinking and action that can directly convert to increased revenues for our clients.”

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
News

Actavis goes up for sale, peaks interest of major Rx companies

BY Alaric DeArment

NEW YORK Icelandic generic drug maker Actavis is for sale and could go for up to $10.8 billion at a time when many generic drug companies find themselves targets of acquisitions.

The fifth largest maker of generic drugs in the world, Actavis became a private company in 2007 after action by majority stakeholder Novator, led by Icelandic billionaire Thor Bjorgolfsson.

According to Reuters, a number of large drug makers could end up buying the company, including Pfizer, Sanofi-Aventis, GlaxoSmithKline and Novartis.

In other news, the Food and Drug Administration announced Friday that it had filed a consent decree and was awaiting the United States District Court for the District of New Jersey’s entry of a permanent injunction forbidding Actavis’ U.S. subsidiary, Actavis Totowa, from manufacturing drugs in its New Jersey factories until the FDA decides the factories are in compliance with current good-manufacturing practice requirements.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
News

Winn-Dixie opens prototype store with expanded grocery departments, pharmacy

BY Michael Johnsen

JACKSONVILLE, Fla. Winn-Dixie Stores on Wednesday opened a prototype store in its existing SaveRite location here featuring everyday low pricing on thousands of items a la Walmart, as well as monthly locked-in specials and special price-drop items in a warehouse format.

“In designing this concept, we spent a great deal of time reviewing our customers’ shopping preferences,” said Dan Portnoy, Winn-Dixie chief merchandising and marketing officer. “We wanted to make sure that the new store would be a true fit for the neighborhoods it serves. … We focused only on those items and services that were most important to our customers, and, as a result, we were able to aggressively cut costs and lower prices throughout the store.”

In addition to enhanced produce and meat departments, the 48,000-square-foot store also has an in-store pharmacy where customers will find 30-day supplies of more than 400 generic drugs for only $3.98 every day. Other features include newly designed warehouse-style shopping carts and popular staple items available for purchase by the case.

SaveRite closed the store Jan. 6, allowing time for associates to work through the afternoon and evening to lower thousands of prices. The company welcomed area leaders and residents to a preview on Tuesday evening where SaveRite donated $5,000 to Paxon Improvement Association. To celebrate the store’s new format, SaveRite will also host a Family Fun Event on Jan. 10.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?